Currently, there are 259.85M common shares owned by the public and among those 166.48M shares have been available to trade.
The company’s stock has a 5-day price change of 12.96% and 12.96% over the past three months. ERAS shares are trading 14.55% year to date (YTD), with the 12-month market performance down to -8.61% lower. It has a 12-month low price of $1.51 and touched a high of $2.97 over the same period. ERAS has an average intraday trading volume of 1.83 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 7.37%, 12.58%, and 16.01% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Erasca Inc (NASDAQ: ERAS) shares accounts for 27.58% of the company’s 259.85M shares outstanding.
It has a market capitalization of $634.03M and a beta (3y monthly) value of 1.16. The earnings-per-share (ttm) stands at -$0.84. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.31% over the week and 6.84% over the month.
Earnings per share for the fiscal year are expected to increase by 6.86%, and -2.98% over the next financial year.
Looking at the support for the ERAS, a number of firms have released research notes about the stock. CapitalOne stated their Overweight rating for the stock in a research note on March 11, 2024, with the firm’s price target at $8. BofA Securities coverage for the Erasca Inc (ERAS) stock in a research note released on January 05, 2024 offered a Neutral rating with a price target of $6. H.C. Wainwright was of a view on October 11, 2023 that the stock is Buy, while Mizuho gave the stock Buy rating on March 30, 2023, issuing a price target of $9. Goldman on their part issued Buy rating on February 24, 2023.
